HIV tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter

被引:35
作者
Yang, YL
Dong, B
Mittelstadt, PR
Xiao, H
Ashwell, JD
机构
[1] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA
[2] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M201687200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV Tat can enhance activation-induced up-regulation of Fas ligand (Fast,), which may contribute to T cell apoptosis in human immune deficiency virus (HIV)-infected individuals. We have assessed functional and physical interactions between Tat and the Egr family of transcription factors (Egr-1, -2, and -3), the latter two of which are major participants in activation-induced Fast, up-regulation. Here we report that whereas Tat itself has no effect on the Fast, promoter, it binds to Egr-2 and -3 and synergizes with them to superinduce expression of a Fast, promoter-driven reporter. A Tat molecule containing a single amino acid substitution that results in the loss of transactivation activity for the HIV long terminal repeat still binds Egr-3 but can no longer enhance Egr-mediated transactivation of the Fast, promoter. Furthermore, the mutated Tat acts as a dominant negative inhibitor, blocking the superinduction of Fast, caused by wild type Tat. Because Tat is present in virus-infected cells and in the serum of HIV-infected individuals, these results suggest that increased expression of Fast, in these circumstances may result from the cooperative activities of activation-induced Egrs and Tat.
引用
收藏
页码:19482 / 19487
页数:6
相关论文
共 69 条
  • [1] HIV-1 Tat protein mimicry of chemokines
    Albini, A
    Ferrini, S
    Benelli, R
    Sforzini, S
    Giunciuglio, D
    Aluigi, MG
    Proudfoot, AEI
    Alouani, S
    Wells, TNC
    Mariani, G
    Rabin, RL
    Farber, JM
    Noonan, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) : 13153 - 13158
  • [2] A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 Nef alleles in lymphocyte activation
    Alexander, L
    Du, ZJ
    Rosenzweig, M
    Jung, JU
    Desrosiers, RC
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (08) : 6094 - 6099
  • [3] CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis
    Algeciras, A
    Dockrell, DH
    Lynch, DH
    Paya, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) : 711 - 720
  • [4] Upregulation of fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
    Badley, AD
    McElhinny, JA
    Leibson, PJ
    Lynch, DH
    Alderson, MR
    Paya, CV
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 199 - 206
  • [5] Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
    Bartz, SR
    Emerman, M
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (03) : 1956 - 1963
  • [6] Baumler CB, 1996, BLOOD, V88, P1741
  • [7] HIV-1 NEF LEADS TO INHIBITION OR ACTIVATION OF T-CELLS DEPENDING ON ITS INTRACELLULAR-LOCALIZATION
    BAUR, AS
    SAWAI, ET
    DAZIN, P
    FANTL, WJ
    CHENGMAYER, C
    PETERLIN, BM
    [J]. IMMUNITY, 1994, 1 (05) : 373 - 384
  • [8] Recruitment of cyclin T1/P-TEFb to an HIV type I long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription
    Bieniasz, PD
    Grdina, TA
    Bogerd, HP
    Cullen, BR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) : 7791 - 7796
  • [9] Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy
    Bohler, T
    Herr, I
    Debatin, KM
    Geiss, M
    Haas, J
    [J]. BLOOD, 1997, 90 (02) : 886 - 887
  • [10] Boykins RA, 1999, J IMMUNOL, V163, P15